Ref ID: 19530
Author:
A De Luca1*, RG Iannitti1, M Borghi1, M Puccetti1, C Galosi1, V Oikonomou1, G Renga1,
A Casagrande1,2, F van de Veerdonk3, L Romani1
Author address:
1Department of Experimental Medicine and Biochemical Sciences, University of Perugia, Perugia, Italy
2Istituto Superiore di Sanita`, Roma, Italy
3Department of Medicine, Radboud University Nijmegen Medical Center, The Netherlands
Full conference title:
6th Advances Against Aspergillosis 2014
Abstract:
Purpose:
Aspergillosis is a life-threatening disease that occurs in immunodepressed patients when infected
with Aspergillus fumigatus. The progressive decline of pulmonary function is due to a vicious
cycle of airways infection and inflammation. Intracellular danger sensing protein complexes
called inflammasomes have been identified and functionally characterized in inflammatory and
non-iflammatory cells, with their relevance to airway diseases. We hypothesized that the heighten
inflammatory response due to inflammasome activation could be responsible for life-threatening
bacterial and fungal infections in Chronic granulomatous disease (CGD) or Cystic Fibrosis (CF)
and that blocking IL-1 receptor could improve inflammation in both Chronic granulomatous disease
(CGD) or Cystic Fibrosis (CF).
Methods:
CGD or CF mice were infected with A. fumigatus and treated with anakinra (a recombinant form
of the naturally occurring IL-1 receptor antagonist) daily. Mice were monitored for survival, local
fungal growth, inflammatory cell recruitment and lung histopathology as well as parameters of
inflammasome activation.
Results:
We found that the heightened inflammatory response to A. fumigatus was associated with an increased
activation of the inflammasome and production of IL-1β in experimental CGD and CF. Anakinra
successfully controlled inflammasome-dependent IL-1β production in response to infectious or
danger signals in CGD and CF mice, an activity to which the restoration of autophagy greatly
contributed.
Conclusion:
Abnormal activation of inflammasome-dependent mechanisms are demonstrable in CGD and CF,
such that blocking IL-1 could be a potential therapeutic option to dampen pathogenic inflammation
in CGD or CF.
Abstract Number: 57
Conference Year: 2014
Link to conference website: http://www.AAA2014.org
New link: NULL
Conference abstracts, posters & presentations
-
Title
Author
Year
Number
Poster
-
v
Teclegiorgis Gebremariam [MS]1, Yiyou Gu [PhD]1, Sondus Alkhazraji [PhD]1, Jousha Quran1, Laura K. Najvar [BS]2, Nathan P. Wiederhold [PharmD]2, Thomas F. Patterson [MD]2, Scott G. Filler [MD]1,3, David A. Angulo (MD)4, Ashraf S. Ibrahim [PhD]1,3*,
2024
91
n/a
-
v
Ruta Petraitiene (US)
2024
90
n/a
-
v
Fabio Palmieri (CH), Junier Pilar
2024
89
n/a
-
v
Evelyne Côté (CA)
2024
88
n/a
-
v
Eliane Vanhoffelen (BE)
2024
87
n/a
-
v
Teclegiorgis Gebremariam, Yiyou Gu, Eman Youssef, Sondus Alkhazraji, Joshua Quran, Nathan P. Wiederhold, Ashraf S. Ibrahim
2024
86
n/a
-
v
Thomas Orasch (DE)
2024
85
n/a
-
v
Julien Alex, Katherine González, Gauri Gangapurwala, Antje Vollrath, Zoltán Cseresnyés, Christine Weber, Justyna A. Czaplewska, Stephanie Hoeppener, Carl-Magnus Svensson, Thomas Orasch, Thorsten Heinekamp, Carlos Guerrero-Sánchez, Marc Thilo Figge, Ulrich S. Schubert, Axel A. Brakhage
2024
84
n/a
-
v
Vasireddy Teja, Bibhuti Saha Hod, Soumendranath Haldar (IN)
2024
83
n/a
-
v
Vasireddy Teja, Bibhuti Saha Hod, Soumendranath Haldar (IN)
2024
82
n/a